Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | GRM8 | O00222 | 1/20 | 0.49 |
| ▸ | GRM6 | O15303 | 1/20 | 0.49 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.49 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2883857 | 0.86 | TSHR (0.53) | ALDH1A1TSHRCYP3A4RECQLEPAS1 | |
| SCHEMBL26352809 | 0.86 | TSHR (0.53) | ALDH1A1TSHRCYP3A4RECQLEPAS1 | |
| SCHEMBL26352787 | 0.86 | TSHR (0.53) | ALDH1A1TSHRCYP3A4RECQLEPAS1 | |
| SCHEMBL2436243 | 0.85 | TSHR (0.56) | ALDH1A1TSHRCYP3A4RECQLGRM8 | |
| SCHEMBL15927423 | 0.84 | TSHR (0.55) | ALDH1A1TSHRCYP3A4RECQLGRM8 | |
| SCHEMBL15854544 | 0.83 | APP (0.57) | ALDH1A1TSHRCYP3A4RECQLCES2 | |
| SCHEMBL27859132 | 0.83 | TSHR (0.54) | ALDH1A1TSHRCYP3A4RECQLGRM8 | |
| SCHEMBL2756243 | 0.83 | GRM8 (0.53) | ALDH1A1TSHRCYP3A4RECQLGRM8 | |
| SCHEMBL16313203 | 0.82 | TSHR (0.53) | ALDH1A1TSHRCYP3A4RECQLGRM8 | |
| SCHEMBL16959578 | 0.82 | TSHR (0.53) | ALDH1A1TSHRCYP3A4RECQLGRM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101668749-A | Novel pyrimidine derivatives 698 | ASTRAZENECA AB | 2010-03-10 | — | — | CN | disclosed |
| EP-2132184-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | AstraZeneca AB (SE) | 2009-12-16 | — | — | EP | disclosed |
| US-20080242663-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | ASTRAZENECA AB (SE) | 2008-10-02 | — | — | US | disclosed |
| WO-2008104754-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | ASTRAZENECA AB (SE) | 2008-09-04 | — | — | WO | disclosed |
| CN-1156451-C | Betz 2-adrenoceptor agonists | ��˹��ŵ�� | 2004-07-07 | — | — | CN | disclosed |
| CN-1353692-A | Betz 2-adrenoceptor agonists | NOVARTIS AG (CH) | 2002-06-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242663-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | EPHB4, EPHB1, NME2 | ALDH1A1 1143/4885TSHR 2708/4885CYP3A4 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.